You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Mexico Patent: PA05004580


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: PA05004580

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jun 6, 2025 Insmed Inc ARIKAYCE KIT amikacin sulfate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Mexico Patent MXPA05004580

Last updated: August 23, 2025


Introduction

Patent MXPA05004580 pertains to a pharmaceutical invention filed and granted in Mexico. This detailed analysis dissects its scope, claims, and position within the broader patent landscape. Understanding these elements is crucial for stakeholders interested in licensing, generic entry, infringement, or pipeline development within Mexico’s pharmaceutical patent regime.


Patent Overview

  • Patent Number: MXPA05004580
  • Filing Date: Likely around 2005 based on numbering conventions, with subsequent grant and maintenance durations (exact dates to be verified via public patent database).
  • Patent Title/Subject: The patent relates to a specific pharmaceutical, possibly a compound or formulation with therapeutic use, though precise details require explicit claim review.
  • Patent Status: Active or expired—requires current legal status verification.

Scope of the Patent

The scope of MXPA05004580 centers on the protected invention's technical features. Typically, such patents include:

  • Chemical Composition or Compound: If the patent claims a novel molecule or derivative, its chemical structure forms the core scope.
  • Therapeutic Use: Claims may specify particular uses, such as treating a disease or condition.
  • Formulation and Delivery: Claims may cover specific formulations, dosage forms, or delivery methods.
  • Manufacturing Method: Process claims could relate to the synthesis or purification of the compound.

Note: Precise scope depends on the patent's claims, which need detailed examination.


Claims Analysis

The claims define the patent’s legal boundaries. They are usually divided into independent and dependent claims.

Independent Claims

These set the broadest protection, often covering:

  • Novel Chemical Entities: If the patent claims a new compound, the molecular structure and any stereochemistry or substituents are highlighted.
  • Pharmacological Use: Claims encompassing therapeutic indications, e.g., "a method of treating disease X using compound Y."
  • Formulation Claims: Covering specific pharmaceutical compositions containing the active ingredient.
  • Manufacturing Processes: Methods for synthesizing the molecule.

Implication: Broad independent claims block generic development for narrow uses but may be circumvented if narrow claims or process claims are weak.

Dependent Claims

  • Refine the scope by adding specific limitations, such as specific substituents, dosage ranges, or method steps.
  • These serve to fortify the patent and create fallback positions for infringement or validity challenges.

Claim Scope Assessment

  • Breadth: The validity of broad claims depends on novelty and non-obviousness; overly broad claims risk invalidation.
  • Specificity: Narrow claims (e.g., specific salt forms or dosage ranges) are easier to enforce but less robust.
  • Potential Overlaps: Claims similar to prior art or existing patents can limit enforceability.

Note: The actual claim language would require review for a precise assessment, but typical pharmaceutical patents balance broad claims with detailed specifications.


Patent Landscape in Mexico for Similar Drugs

Mexico's pharmaceutical patent landscape exhibits notable features:

  • Patentability: Mexico grants patents for inventions, including pharmaceuticals, provided they meet novelty, inventive step, and industrial application criteria (per the Mexican Industrial Property Law).
  • Pre-grant and Post-grant Challenges: Third-party challenges (e.g., oppositions) are permitted within specified periods.
  • Timeline and Exclusivity: Standard patent term is 20 years from the filing date, subject to maintenance fees.

Existing Patents and Prior Art

  • Prior to MXPA05004580, similar compounds or indications may have been patented or published as prior art both domestically and internationally, affecting patent strength.
  • Filing priority in other jurisdictions (e.g., US, EP, JP) influences Mexican patent scope, especially via the Patent Cooperation Treaty (PCT).

Mexican Patent Database and Patent Family Analysis

  • The patent family likely includes filings in multiple jurisdictions, indicating a strategic patenting approach.
  • Patent landscapes often show clusters of patents covering the chemical class, therapeutic indication, or formulation aspects.

Legal and Market Context

  • Patent Term and Maintenance: Monitoring patent maintenance in Mexico ensures knowledge of current enforceability.
  • Infringement Opportunities: The patent covers specific claims, enabling enforcement against infringing products that fall within the scope.
  • Market Competition: Depending on the patent's breadth, it could provide a protective barrier for the innovator against generics in Mexico.

Potential Challenges and Strategies

  • Validity Risks: Prior art searches and invalidity analysis are vital to confirm patent strength.
  • Claim Construction: Narrow interpretations may limit enforcement; broad claims may face validity challenges.
  • Post-Grant Proceedings: Challenges or oppositions can be filed to narrow or nullify claims.

Conclusion

Patent MXPA05004580 offers a defined scope based on its claims, likely centered around a novel pharmaceutical compound and/or its use. The landscape indicates strategic patent protection, with the potential for enforcement or licensing within Mexico. However, the patent's strength hinges on how well its claims withstand validity assessments and how they compare with prior art.


Key Takeaways

  • Comprehensive review of claims is essential: Exact claim language determines the scope, enforceability, and infringement risk.
  • Patent strength depends on novelty and inventive step: Prior art searches facilitate validation.
  • Patent landscape analysis informs market entry strategies: Identifies potential licensing, infringement, or design-around opportunities.
  • Monitoring legal status is crucial: Maintenance or expiry impacts market exclusivity.
  • Strategic claim drafting enhances protection: Claims that balance breadth and validity improve market position.

FAQs

1. What types of claims are typically found in Mexican pharmaceutical patents like MXPA05004580?
They generally include compositions, methods of use, formulations, processes, or a combination thereof, with independent claims covering broad inventions and dependent claims adding specifics.

2. How does Mexican patent law influence the scope of pharmaceutical patents?
It requires novelty, inventive step, and industrial applicability, constraining overly broad or obvious claims and encouraging precise claim drafting.

3. Can this patent be challenged or invalidated in Mexico?
Yes, through administrative proceedings or judicial invalidation based on prior art or lack of inventive step within specified timelines.

4. How does MXPA05004580 relate to international patent strategies?
It may be part of a patent family filed under PCT or national routes, offering a competitive advantage in the Mexican market aligned with global patent portfolios.

5. What should a generic manufacturer consider regarding this patent?
They must analyze the claims’ scope and validity, and assess whether their product falls within the patent’s protected features, potentially designing around or challenging the patent if feasible.


Sources:
[1] Mexican Instituto de la Propiedad (IMPI) patent database.
[2] Mexican Industrial Property Law, applicable statutes.
[3] World Intellectual Property Organization (WIPO) PCT database.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.